Introducing a New Biomarker Named R2*-BOLD-MRI Parameter to Assess Treatment Response in Osteosarcoma.
Chu Hyun KimJi Hyun LeeJi Won LeeEunju KimSang-Hee ChoiPublished in: Journal of magnetic resonance imaging : JMRI (2021)
5 TECHNICAL EFFICACY: Stage 2.